drug
as of 2026-07-01Sertindole
MeSH C066304
at a glance
small molecule
Pre-approval / investigational in the US
Developed by H. Lundbeck A/S
12 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
SchizophreniaDepressionPsychosomatic DisordersCognitionSchizophrenia Spectrum and Other Psychotic DisordersSchizophreniaAnxiety DisordersDepressionCognitive DysfunctionPsychotic DisordersSchizoaffective DisordersPsychophysiologic DisordersDementiaAnxiety DisordersSchizophrenia and Disorders With Psychotic FeaturesDementia
Trials
12
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
NCT02307396Phase 4Completed
The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia
NCT02021201Phase 4Terminated
Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)
NCT00885690—Terminated
The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients
NCT00629252—Terminated
Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone
NCT00480844Phase 4Unknown
Safety Study of an Antipsychotic, Sertindole, to Treat Schizophrenia
NCT00763438Phase 4Completed
Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia
NCT00654706Phase 3Completed
Exploratory Cognition Study of Sertindole in Patients With Schizophrenia
NCT00759421Phase 3Completed
Sertindole in Asian Patients With Schizophrenia
NCT00864045Phase 3Completed
Study on Metabolic Parameters of Sertindole in Patients With Schizophrenia
NCT00759460Phase 3Completed
Safety Study of Sertindole Versus Risperidone Under Normal Conditions of Use
NCT00856583Phase 3Completed
KOLs & investigators
10
Stefan Leucht, ProfessorKOL score 87
Mark Weiser, MDKOL score 9
Bob Oranje, PHDKOL score 8
Birgitte Fagerlund, PhDKOL score 8
Helge Frieling, Prof., MDKOL score 5
René S. Kahn, M.D., Ph.D.KOL score 5
Birte Y Glenthoj, professorKOL score 0
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
KOL
Stefan Leucht, Professor
personKOL score 87
Mark Weiser, MD
personKOL score 9
Bob Oranje, PHD
personKOL score 8
Birgitte Fagerlund, PhD
personKOL score 8